Mentions:
1: Nigel Mills (Con - Amber Valley) There is a high incidence of respiratory disease in Amber Valley. - Speech Link
2: James Sunderland (Con - Bracknell) Government for the recent SEND review, the significant increase in resources and the bespoke safety valve - Speech Link
3: Rishi Sunak (Con - Richmond (Yorks)) Bracknell Forest Council has worked positively with the Department for Education through the safety valve - Speech Link
4: Naz Shah (Lab - Bradford West) One constituent had to sell his wedding gifts, and his father had a heart attack with the stress. - Speech Link
Asked by: Virendra Sharma (Labour - Ealing, Southall)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to tackle disparities in access to medical treatment for heart valve disease.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
In the development of the Major Conditions Strategy, we are committed to focusing on the six major groups, which includes cardiovascular disease. As part of the policy development process, the Major Conditions Strategy will consider the full range of health disparities that may be experienced by different groups, including ethnic and gender disparities.
Asked by: Virendra Sharma (Labour - Ealing, Southall)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she plans to include additional material on heart valve disease in the Major Conditions Strategy.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
In the development of the Major Conditions Strategy, we are committed to focusing on the six major groups of conditions, which includes cardiovascular disease. Aligning work across several groups of conditions allows us to focus on where there are similarities in approach to ensure care is better centred around the patient, health and care resources are used most effectively, and that there is effective integration, both within and between treatment pathways.
This strategy does not seek to describe everything that is being done or could be done to meet the challenges of specific diseases within the major conditions. Instead, we are focusing on developing a strategic approach to inform the wide range of decisions health and care organisations make when determining how best to care for the people they serve.
Asked by: Virendra Sharma (Labour - Ealing, Southall)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she has made an estimate of the number of heart valve disease patients treated in non-elective settings in the last 12 months; and whether she has made an assessment of the potential impact of this treatment on (a) hospital capacity and (b) patient's quality of life.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
NHS England’s Hospital Episode Statistics tell us that there were 11,581 non-elective hospital admissions for heart valve disease in 2022/23. There has been no specific assessment made of the potential impact of this treatment on hospital capacity or on patients quality of life. The National Health Service will, at all times, aim to provide patients with the care which responds to their needs. This includes patients who are admitted to hospital through non-elective routes for heart valve disease.
The NHS is also taking action to identify cardiovascular disease before a patient is admitted to hospital. The NHS has rolled out free blood pressure checks to people over the age of 40 in community pharmacies to detect thousands more people living with hypertension earlier. This means more people can access simple, low-cost treatments that will reduce their risk of death or serious illness from cardiovascular disease. Furthermore, 108 community diagnostic centres have opened that have delivered more than 3.9 million tests, including those that detect cardiovascular disease.
NHS England has included hypertension case-finding, optimal management, and lipid optimal management as one of its five clinical areas of focus requiring accelerated improvement within the Core20PLUS5 approach. The Core20PLUS5 informs action to reduce healthcare inequalities at both national and system level.
Apr. 10 2024
Source Page: Service Inquiry into the death of a service person on 24 November 2022 following completion of a loaded march at CatterickFound: screening and since no disease was found during the PM, they had nothing to use as a guide to improve
Apr. 09 2024
Source Page: MHRA FOI performance dataFound: , furthermore, if a patient becomes ill with same symptoms of the disease the vaccine is designed to
Mar. 28 2024
Source Page: Code of safe working practices for merchant seafarers (COSWP) 2024Found: First treat any casualty who is not breathing or whose heart has stopped.
Mar. 19 2024
Source Page: FOI responses published by MOD: week commencing 18 March 2024Found: Candidates with established heart disease are graded P8, except in the following specific circumstances
Mar. 14 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023Found: disease, heart failure, atrial fibrillat ion, valvular heart disease, coronary artery disease, h
Mar. 14 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023Found: and symptoms NEC Palpitations 9 0 Endocarditis NEC Endocarditis noninfective 1 1 Heart